Atrium Therapeutics, Inc. (RNA)
Nasdaq: RNA · CIK 0002093101 · United States
Every official Atrium Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RNA filings
Atrium Therapeutics, Inc. documents
- Atrium Therapeutics, Inc. 10-K 2026RNA 10-K 2026: annual report for fiscal 2026
- Atrium Therapeutics, Inc. 10-K 2025RNA 10-K 2025: annual report for fiscal 2025
- Atrium Therapeutics, Inc. 10-K 2024RNA 10-K 2024: annual report for fiscal 2024
- Atrium Therapeutics, Inc. 10-K 2023RNA 10-K 2023: annual report for fiscal 2023
- Atrium Therapeutics, Inc. 10-K 2022RNA 10-K 2022: annual report for fiscal 2022
- Atrium Therapeutics, Inc. 10-Q 2026RNA 10-Q 2026: quarterly report for fiscal 2026
- Atrium Therapeutics, Inc. 10-Q 2025RNA 10-Q 2025: quarterly report for fiscal 2025
- Atrium Therapeutics, Inc. 10-Q 2024RNA 10-Q 2024: quarterly report for fiscal 2024
- Atrium Therapeutics, Inc. 10-Q 2023RNA 10-Q 2023: quarterly report for fiscal 2023
- Atrium Therapeutics, Inc. 10-Q 2022RNA 10-Q 2022: quarterly report for fiscal 2022
- Atrium Therapeutics, Inc. 8-K 2026RNA 8-K 2026: current report for fiscal 2026
- Atrium Therapeutics, Inc. 8-K 2025RNA 8-K 2025: current report for fiscal 2025
- Atrium Therapeutics, Inc. 8-K 2024RNA 8-K 2024: current report for fiscal 2024
- Atrium Therapeutics, Inc. 8-K 2023RNA 8-K 2023: current report for fiscal 2023
- Atrium Therapeutics, Inc. 8-K 2022RNA 8-K 2022: current report for fiscal 2022
- Atrium Therapeutics, Inc. DEF 14A 2026RNA DEF 14A 2026: proxy statement for fiscal 2026
- Atrium Therapeutics, Inc. DEF 14A 2025RNA DEF 14A 2025: proxy statement for fiscal 2025
- Atrium Therapeutics, Inc. DEF 14A 2024RNA DEF 14A 2024: proxy statement for fiscal 2024
- Atrium Therapeutics, Inc. DEF 14A 2023RNA DEF 14A 2023: proxy statement for fiscal 2023
- Atrium Therapeutics, Inc. DEF 14A 2022RNA DEF 14A 2022: proxy statement for fiscal 2022
- Atrium Therapeutics, Inc. Form 4 2026RNA Form 4 2026: insider trading filing for fiscal 2026
- Atrium Therapeutics, Inc. Form 4 2025RNA Form 4 2025: insider trading filing for fiscal 2025
- Atrium Therapeutics, Inc. Form 4 2024RNA Form 4 2024: insider trading filing for fiscal 2024
- Atrium Therapeutics, Inc. Form 4 2023RNA Form 4 2023: insider trading filing for fiscal 2023
- Atrium Therapeutics, Inc. Form 4 2022RNA Form 4 2022: insider trading filing for fiscal 2022
- Atrium Therapeutics, Inc. S-1 2026RNA S-1 2026: registration statement for fiscal 2026
- Atrium Therapeutics, Inc. S-1 2025RNA S-1 2025: registration statement for fiscal 2025
- Atrium Therapeutics, Inc. S-1 2024RNA S-1 2024: registration statement for fiscal 2024
- Atrium Therapeutics, Inc. S-1 2023RNA S-1 2023: registration statement for fiscal 2023
- Atrium Therapeutics, Inc. S-1 2022RNA S-1 2022: registration statement for fiscal 2022
- Atrium Therapeutics, Inc. 13F 2026RNA 13F 2026: institutional holdings for fiscal 2026
- Atrium Therapeutics, Inc. 13F 2025RNA 13F 2025: institutional holdings for fiscal 2025
- Atrium Therapeutics, Inc. 13F 2024RNA 13F 2024: institutional holdings for fiscal 2024
- Atrium Therapeutics, Inc. 13F 2023RNA 13F 2023: institutional holdings for fiscal 2023
- Atrium Therapeutics, Inc. 13F 2022RNA 13F 2022: institutional holdings for fiscal 2022
More companies